Should prenatal testing be used to detect intersex conditions?

Celeste Orr writes in The Guardian that disorders of sex should not be a legitimate target of prenatal screening using PGD or genetic screening. Scientists in the UK have already introduced noninvasive genetic screening for congenital adrenal hyperplasia (CAH), one of the more common intersex disorders, on a research protocol.

Eliminating intersex babies is not a legitimate use of genetic embryo testing:It is done to reinforce the inadequate sex binary and even to police non-heterosexual, queer attractions or acts.